Could two pills at once boost HIV protection?
NCT ID NCT07349758
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a one-time dose of two F/TAF tablets (a medicine used to prevent HIV) works in healthy adults. Researchers want to see how much of the drug gets inside cells over 14 days. 24 healthy volunteers will take the pills and have their blood tested. The goal is to find out if a higher single dose could be a simpler way to prevent HIV.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins University School of Medicine
RECRUITINGBaltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?